Literature DB >> 21127736

Cullins and cancer.

Jennifer Lee1, Pengbo Zhou.   

Abstract

The cullin family of ubiquitin ligases can potentially assemble hundreds of RING-type E3 complexes (CRLs) by utilizing different substrate receptors that share common interaction domains. Cullin receptors dictate substrate specificity, and cullin-mediated substrate degradation controls a wide range of cellular processes, including proliferation, differentiation, and apoptosis. Dysregulation of cullin activity has been shown to contribute to oncogenesis through the accumulation of oncoproteins or the excessive degradation of tumor suppressors. In this review, we will discuss cullin complexes and their substrates, the regulatory pathways that affect cullin activity, and the mechanisms by which cullins may facilitate or inhibit carcinogenesis.

Entities:  

Keywords:  cancer; cullin; ubiquitin

Year:  2010        PMID: 21127736      PMCID: PMC2994581          DOI: 10.1177/1947601910382899

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  173 in total

1.  Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage.

Authors:  Hengbin Wang; Ling Zhai; Jun Xu; Heui-Yun Joo; Sarah Jackson; Hediye Erdjument-Bromage; Paul Tempst; Yue Xiong; Yi Zhang
Journal:  Mol Cell       Date:  2006-05-05       Impact factor: 17.970

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Authors:  Haojie Huang; Kevin M Regan; Fang Wang; Diping Wang; David I Smith; Jan M A van Deursen; Donald J Tindall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

4.  TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.

Authors:  Kohichiroh Yasui; Shigeki Arii; Chen Zhao; Issei Imoto; Masakazu Ueda; Hisaki Nagai; Mitsuru Emi; Johji Inazawa
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

5.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development.

Authors:  K Chan; R Lu; J C Chang; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2.

Authors:  Yan Liu; Cyrus V Hedvat; Shifeng Mao; Xin-Hua Zhu; Jinjuan Yao; Hoang Nguyen; Andrew Koff; Stephen D Nimer
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Skp2 enhances polyubiquitination and degradation of TIS21/BTG2/PC3, tumor suppressor protein, at the downstream of FoxM1.

Authors:  Tae Jun Park; Ji Yeon Kim; Su Hyun Park; Hong Seok Kim; In Kyoung Lim
Journal:  Exp Cell Res       Date:  2009-07-14       Impact factor: 3.905

8.  BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.

Authors:  Jeong Eun Kwon; Muhnho La; Kyu Hee Oh; Young Mi Oh; Gi Ryang Kim; Jae Hong Seol; Sung Hee Baek; Tomoki Chiba; Keiji Tanaka; Ok Sun Bang; Cheol O Joe; Chin Ha Chung
Journal:  J Biol Chem       Date:  2006-03-08       Impact factor: 5.157

Review 9.  Proteasome inhibitors in the treatment of multiple myeloma.

Authors:  J J Shah; R Z Orlowski
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528

10.  HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.

Authors:  Jean-Philippe Belzile; Ghislaine Duisit; Nicole Rougeau; Johanne Mercier; Andrés Finzi; Eric A Cohen
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

View more
  40 in total

1.  A Cul4 E3 ubiquitin ligase regulates histone hand-off during nucleosome assembly.

Authors:  Junhong Han; Hui Zhang; Honglian Zhang; Zhiquan Wang; Hui Zhou; Zhiguo Zhang
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

2.  E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation.

Authors:  Anand Thirunavukarasou; Prachi Singh; Gokulapriya Govindarajalu; Venkateshwarlu Bandi; Sudhakar Baluchamy
Journal:  Mol Cell Biochem       Date:  2014-01-23       Impact factor: 3.396

3.  Suppression of autophagy during mitosis via CUL4-RING ubiquitin ligases-mediated WIPI2 polyubiquitination and proteasomal degradation.

Authors:  Guang Lu; Juan Yi; Andrea Gubas; Ya-Ting Wang; Yihua Wu; Yi Ren; Man Wu; Yin Shi; Chenxi Ouyang; Hayden Weng Siong Tan; Tianru Wang; Liming Wang; Nai-Di Yang; Shuo Deng; Dajing Xia; Ruey-Hwa Chen; Sharon A Tooze; Han-Ming Shen
Journal:  Autophagy       Date:  2019-03-30       Impact factor: 16.016

4.  It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53.

Authors:  Ian M Love; Steven R Grossman
Journal:  Genes Cancer       Date:  2012-03

Review 5.  The role of cullin proteins in gastric cancer.

Authors:  Peng Chen; Guo-Dong Yao
Journal:  Tumour Biol       Date:  2015-10-15

6.  Network-based identification of key proteins involved in apoptosis and cell cycle regulation.

Authors:  L Wu; N Zhou; R Sun; X D Chen; S C Feng; B Zhang; J K Bao
Journal:  Cell Prolif       Date:  2014-06-02       Impact factor: 6.831

7.  Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.

Authors:  Anjali Teckchandani; George S Laszlo; Sergi Simó; Khyati Shah; Carissa Pilling; Alexander A Strait; Jonathan A Cooper
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

Review 8.  Dishevelled: A masterful conductor of complex Wnt signals.

Authors:  Monica Sharma; Isabel Castro-Piedras; Glenn E Simmons; Kevin Pruitt
Journal:  Cell Signal       Date:  2018-03-17       Impact factor: 4.315

Review 9.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 10.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.